+118%

est. 2Y upside i

HealthcareSeries C

Candid Health is building a modern medical payments platform that enables healthcare providers to focus on delivering high-quality, affordable and accessible care, rather than spending half their time figuring out how to get paid by insurance.

Rank

#297

Sector

Healthcare Technology

Est. Liquidity

~3Y

Data Quality

Data: Medium

Candid Health offers significant upside potential (118% expected) driven by 250% YoY growth and a massive TAM, but faces high incumbent competition and a dilutive preference stack.

Last updated: July 19, 2026

Bull (20%)+200%

Candid Health achieves IPO within 2 years, maintaining strong growth and expanding margins; exit multiple holds at 7x forward revenue, but stage cap limits upside to 200%. Projected revenue $415M supports $2.9B exit, capped at $1.35B.

Base (35%)+251%

Candid Health continues high growth but faces competition from incumbents; multiple converges to 5x forward revenue, implying $2.075B exit. After preference and dilution, common stock upside ~251%.

Bear (45%)-22%

Incumbent competition intensifies, slowing growth to 100% YoY in year 1 and 50% in year 2; multiple compresses to 3x on $180M revenue, exit $540M. After preference and dilution, common stock loses ~22%.

Est. time to liquidity~2.5 years

Preference Stack Risk

high

Funding Intensity

22%

Total preferred stock of $99.5M represents 22.1% of current $450M valuation, posing significant overhang for common stock in downside scenarios.

Dilution Risk

high

With $99.5M total funding and high burn rate, Candid Health may need additional capital within 24 months, diluting common equity by ~20%.

Secondary Liquidity

none

No secondary market observed; employees likely cannot sell shares until liquidity event.

Engineering 16 roles

People 4 roles

Sales 4 roles

Billing Team 3 roles

Delivery / Customer Operations 2 roles

Finance 2 roles

Marketing 2 roles

Design 1 role

Facilities 1 role

Leadership Overhead 1 role

Legal 1 role

Product 1 role

View all 38 open roles at Candid Health

Last updated: March 10, 2026

Questions to Ask at the Interview

Strategic questions based on Candid Health's data — designed to show you've done your homework.

  • 1

    How does Candid Health plan to defend against incumbent AI integration from R1 RCM and Change Healthcare?

  • 2

    What is the unit economics per provider, and how does the percentage-of-collections model scale with larger clients?

  • 3

    What is the expected timeline to liquidity, and does the company consider secondary sales for employees?

Community

Valuation Sentiment

Our model estimates +118% upside. What do you think?

Anonymous. Do not share material non-public information.


Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.